Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-418786
Filing Date
2013-10-30
Accepted
2013-10-30 16:59:17
Documents
12
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d599827d10q.htm 10-Q 472719
2 EX-10.1 d599827dex101.htm EX-10.1 22445
3 EX-31.1 d599827dex311.htm EX-31.1 6102
4 EX-31.2 d599827dex312.htm EX-31.2 6056
5 EX-32.1 d599827dex321.htm EX-32.1 3531
6 EX-32.2 d599827dex322.htm EX-32.2 3516
  Complete submission text file 0001193125-13-418786.txt   3075281

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT idix-20130930.xml EX-101.INS 293419
8 XBRL TAXONOMY EXTENSION SCHEMA idix-20130930.xsd EX-101.SCH 35850
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE idix-20130930_cal.xml EX-101.CAL 44859
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE idix-20130930_def.xml EX-101.DEF 181544
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE idix-20130930_lab.xml EX-101.LAB 265479
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idix-20130930_pre.xml EX-101.PRE 215557
Mailing Address 320 BENT STREET CAMBRIDGE MA 02141
Business Address 320 BENT STREET CAMBRIDGE MA 02141 617-995-9800
IDENIX PHARMACEUTICALS INC (Filer) CIK: 0001093649 (see all company filings)

EIN.: 450478605 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-49839 | Film No.: 131179961
SIC: 2834 Pharmaceutical Preparations